Post TAVI pacemaker implantation does not increase mortality

Original Title: Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. A Systematic Review and Meta-Analysis.
Reference: Ander Regueiro et al. Circ Cardiovasc Interv. 2016 May;9(5).

 

Available data on the clinical impact of the new-onset left bundle branch block (LBBB) and the need of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) remain controversial.

The aim of this meta-analyzis was, on one hand, to assess the impact of the new-onset LBBB and PPI on all-cause mortality at one year and, on the other hand, to determine the new-onset LBBB predictive value on the need of PPI.

In all, this meta-analyzis included 17 studies with 11788 patients with data on the impact of the new-onset LBBB and the need of PPI. The new-onset LBBB post TAVI was associated with a greater need of PPI (RR 2.18; CI 95%, 1.28 to 3.70) and a higher risk of cardiac death (RR 1.39; CI 95% 1.04 to 1.86) as well as a tendency to increase all-cause mortality (RR 1.21; CI 95% 0.98 to 1.50).

The need of PPI post TAVI was not associated to an increase in all-cause mortality at one year (RR 1.03; CI 95% 0.9 to 1.18). In fact, it showed a tendency to have a protective effect against cardiac death (RR 0.78; CI 95% 0.60–1.03).

Conclusion
The new-onset left bundle branch block post TAVI is a risk marker of cardiac death and need of PPI at one year follow up. The need of PPI immediately post implantation, was not associated with an increase in mortality.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....